abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
In the last 90 days, abrdn Life Sciences Investors insiders filed 1 open-market purchase and 0 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $156.5M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding abrdn Life Sciences Investors changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 73 | 1 | 83 | +11 |
| Shares | 9.49M | 2.14K | 8.89M | −603.2K (−6.4%) |
| Value | $124.5M | $28.1K | $112.8M | −$11.7M (−9.4%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held abrdn Life Sciences Investors at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Formidable Asset Management, LLC | 63,979 | $811.9K | 0.14% |
| Shaker Financial Services, LLC | 23,430 | $297.3K | 0.12% |
| Samalin Investment Counsel, LLC | 20,416 | $259.1K | 0.11% |
| Wedbush Securities Inc | 11,750 | $149.0K | 0.01% |
| Quantedge Capital Pte Ltd | 11,520 | $146.2K | 0.05% |
| Envestnet Asset Management Inc | 11,058 | $140.3K | 0.00% |
| Millennium Management LLC | 10,658 | $135.3K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 10,522 | $134.0K | 0.00% |
| Wealthcare Advisory Partners LLC | 10,301 | $130.7K | 0.00% |
| Nexus Investment Management ULC | 1,489 | $27.2K | 0.00% |
| Costello Asset Management, INC | 1,656 | $21.0K | 0.01% |
| Geneos Wealth Management Inc. | 764 | $9.70K | 0.00% |
| WPG Advisers, LLC | 169 | $2.15K | 0.00% |
| Garde Capital, Inc. | 100 | $1.27K | 0.00% |
| Coldstream Capital Management Inc | 39 | $495 | 0.00% |
| Northwestern Mutual Wealth Management Co | 37 | $470 | 0.00% |
| JPMorgan Chase & Co | 5 | $63 | 0.00% |
| Harbour Investments, Inc. | 4 | $51 | 0.00% |
Sold out (7)
Institutions that held abrdn Life Sciences Investors at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Sit Investment Associates Inc | 417,064 | $5.47M |
| Janney Montgomery Scott LLC | 91,398 | $1.20M |
| Clough Capital Partners L P | 38,519 | $505.4K |
| Jane Street Group, LLC | 22,098 | $289.9K |
| Sanctuary Advisors, LLC | 12,180 | $172.5K |
| FNY Investment Advisers, LLC | 1,600 | $20.0K |
| Capital A Wealth Management, LLC | 455 | $5.97K |
Not filed for Q1 2025 yet (1)
Institutions that held abrdn Life Sciences Investors at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Global Retirement Partners, LLC | 2,140 | $28.1K |